A recent meta-analysis found that pulmonary arterial hypertension (PAH) therapies did not worsen arterial oxygenation in patients with PH associated with lung disease.
bmjopenrespres.bmj.com/content/12/1/e…
bmjopenrespres.bmj.com/content/12/1/e…